← Timeline

TSM · The Yield — Multi-Analyst Outlook 2026–2031

TSM · Oct 20, 2026 · Analysis · Claude

⇆ Compare
TSM$425.08▼ 12.5% off Oct 5 close high52-wk $266.82 – $487.47As of Oct 20, 2026

Independent analysis of TSM — “TSM · The Yield — Multi-Analyst Outlook 2026–2031”, published Oct 20, 2026 as part of Stock Timelines, a running journal of independent equity research. Featuring consensus target $584, projected target $874 (5y).

Key Research Takeaways: TSM · The Yield — Multi-Analyst Outlook 2026–2031

Tickers Analyzed
TSM
Consensus Price Target
$584
Projected Price Target (5y)
$874
Spot Price at Analysis
$425.08 (▼ 12.5% off Oct 5 close high)
52-Week Range
$266.82 - $487.47
Publication Date
Oct 20, 2026
Research Provider
Claude
01 · Equity deep-dive — synthesized analyst desk
TSM
$425.08 ▼ 12.5% off Oct 5 close high
NYSE ADR · SEMICONDUCTOR FOUNDRYMKT CAP ≈ $2.20T (ADR BASIS)52-WK $266.82 – $487.47AS OF OCT 20, 2026 CLOSE

Every leading-edge wafer is spoken for. The stock keeps asking whether the bet will yield.

TSMC just posted a record quarter — revenue +41% in dollars, EPS +69%, gross margin 66.4% — and raised 2026 growth to about 44%. The stock fell anyway, 12.5% from its Oct 5 high, because the market is pricing one question: does AI demand keep clearing a $60–64B-a-year capex bet, or is this peak yield? Six analyst lenses, three scenarios, four time horizons.

The verdict · TL;DR
One question decides the stock: does AI demand keep clearing a $60–64B-a-year capex bet at 65%+ gross margins, or does the first real doubt about AI spending reprice TSMC as a cyclical? Earnings keep beating, but the multiple has fallen from ≈24.5x to ≈19.5x forward while capex climbs. Our bear-tilted weights (30/45/25) still give a probability-weighted gain. The setup is attractive, but the downside is not small.
5-yr · prob-weighted
$885
+108% vs $425.08
52-week playback · where the tape sits ❚❚ Mid-range, off the highs
$425.08 · Oct 20, 2026 consensus $584 · +37%
$266.82 · 52-wk low · Nov 21 ’25 $487.47 · 52-wk high · Oct 5 ’26
Price history + cone of outcomes · Dec 2024 → 2031
HISTORICALBULLBASEBEARPROB-WTDSTREET 12-MO
$100$200$400$800$1,600 Jan ’25Jul ’25Jan ’26Jul ’2620272028202920302031 $486 high · Oct 5 ’26 $267 low · Nov 21 ’25 $512$628$720 $1,496$874$392 $885 TODAY · $425.08

Gray line = TSM’s actual price from dated anchor prices (Dec 31 ’24 $197.49 → Apr ’25 low $134 → Jun 30 ’26 close $477.57 → Oct 5 ’26 close $485.80 high → $425.08 today); intermediate months are not drawn because dated closes were not available for them. Colored paths = synthesized scenario midpoints, probability-weighted (bear 30% · base 45% · bull 25%; bear-tilted because AI sentiment is crowded and capex is rising). Log price axis, mid-year marks. Clay circle = Wall Street 12-month consensus ≈ $584 (S&P Global, 21 analysts, range $440–$1,000; 14 Strong Buy, 6 Buy, 1 Hold, 0 Sell).

Re-weight the scenarios

Those probabilities are a judgment call — so make them yours. Drag to set how likely the bear and bull cases are (base takes the remainder); the blended target, the dotted line on the chart, the wafer yield map below and the prob-weighted row of the scenario cards all update live.

30% bear 45% base 25% bull
Blended 5-yr expected $885 +108% vs $425.08

The yield map. One wafer, 100 dice, each die is one point of probability. Terracotta dice are bear-case outcomes, blue are base, olive are bull. Drag the sliders and the map re-cuts: the more the wafer yields olive, the higher the blended target above.

$46.72B
Q3’26 revenue · +41% YoY (US$)
66.4%
Gross margin · op. margin 58.7%
$4.60
EPS per ADR · NT$29.43 · +69%
$53.3B
Q4 guide midpoint · +58% YoY
≈44%
2026 revenue growth guide (US$)
68%
HPC share of revenue · 2nm = 8% of wafers
$60–64B
2026 capex budget (unchanged)
$100B
Net cash (S&P) · TTM FCF $45.6B
02 · The panel — six ways to read the same tape

Six analyst lenses, six answers

The same fundamentals support wildly different conclusions depending on the framework. Each lens is a synthesized perspective with its own 12-month target (an explicit multiple on next-twelve-months EPS). Panel mean ≈ $471, range $273–$610.

Growth / Momentum PM

The Toll Collector

Full-year 2026 revenue growth guided to ≈44% (up from “slightly above 40%” in July), Q4 guided at +58% YoY at the midpoint, and Street EPS compounding ≈35% into 2027. Management called demand “well above” supply and kept the AI-accelerator CAGR in the high-50s%. A franchise growing like this earns a premium multiple, not a de-rating.

12-MO TARGET $610 · 22x NTM EPS of ≈$27.7
Value / FCF / Quality

The Cash Counter

Superb returns (ROIC ≈60%) and ≈$100B of net cash, but TTM free cash flow of $45.6B is only a ≈2.4% yield on the stock, a $60–64B capex budget is rising, and the dividend yield is ≈0.75%. Great business, fair price: the margin of safety is thin when the cash is all being re-invested.

12-MO TARGET $472 · 17x NTM EPS of ≈$27.7
Bear / Disruption Skeptic

The Capex Cliff

Record profit already failed to lift the stock: the Oct 14–16 AI selloff was set off by a post on CoreWeave’s debt, a Broadcom CEO casino analogy, and rate-hike worries. TSMC itself guides 2026–28 capex “significantly higher” than the prior three years and 2nm plus overseas fabs dilute gross margin 2–4 points. If customers’ AI spend digests, fixed costs bite.

12-MO TARGET $273 · 13x depressed EPS of ≈$21
Moat / Competitive Strategy

The Only Foundry at the Frontier

2nm already reached 8% of wafer revenue (3% a quarter earlier), 3nm 33%, CoWoS demand “remained strong,” and gross margin of 66.4% printed inside guidance while the ramp dilutes it. Samsung is reported to be turning to TSMC for Nvidia’s next AI memory. The moat is process lead plus packaging plus trust, and no rival is close.

12-MO TARGET $569 · 20.5x NTM EPS of ≈$27.7
Quant / Technical

The Reset

Price sits between the 50-day ($434.50) and 200-day ($396.16) averages with RSI ≈42, 12.5% below the Oct 5 closing high. Forward P/E has compressed to ≈19.5x from ≈24.5x in January: earnings rose and the multiple fell. Mean reversion to ≈21x is the technician’s trade.

12-MO TARGET $457 · 21x today’s NTM EPS of ≈$21.78
Macro / Sector Strategist

The Rate Strategist

Press coverage ties the selloff to rate-hike fears: Taiwan’s index had its worst week since April 2025, KOSPI fell nearly 9%, and a Bloomberg Asia chip index sat nearly 19% below its June peak. With tariff terms, an NT$ swing risk and Taiwan concentration on top, growth is real but the multiple is the swing factor.

12-MO TARGET $444 · 16x NTM EPS of ≈$27.7
03 · Wall Street’s read

Wall Street 12-month price targets

What the sell-side expects over the next year. Bars are sorted low to high; the dashed line is today’s $425.08 — seven of eight selected targets sit above it.

Consensus ≈ $584 (+37%) · eight recent actions, S&P range $440–$1,000
BUYHOLDSELL
JLPascual $262 D.A. Davidson $500 Stifel Nicolaus $520 Bernstein $554 Freedom Capital $560 Needham $560 BofA Securities $620 Barclays $670 TODAY · $425.08

Eight of the most recent individual actions (Oct 15–19, 2026, TipRanks via StockAnalysis); the full consensus is $584.39 mean / $557.50 median across 21 analysts (S&P Global). Source conflict: S&P’s lowest target is $440, but TipRanks shows JLPascual downgrading to Sell with a $262 target on Oct 19 — we show both. Several desks raised targets after the print (Bernstein $430→$554, Needham $530→$560, Barclays $665→$670) even as the stock fell.

04 · Price scenarios — 1 / 2 / 3 / 5 years

Where the road leads

Synthesized scenario midpoints (mid-year), each equal to next-twelve-months EPS × an exit multiple. Returns are versus today’s $425.08. These are illustrative frameworks, not predictions; five-year outcomes hinge on whether AI demand and TSMC’s pricing power hold.

1 Year

Mid-2027
Bull$756+78%
Base$512+20%
Bear$260−39%
Prob-wtd$497+17%

2 Years

Mid-2028
Bull$990+133%
Base$628+48%
Bear$280−34%
Prob-wtd$614+44%

3 Years

Mid-2029
Bull$1,162+173%
Base$720+69%
Bear$333−22%
Prob-wtd$714+68%

5 Years

Mid-2031
Bull$1,496+252%
Base$874+106%
Bear$392−8%
Prob-wtd$885+108%
▸ Bull case — show the assumptions & math
AI build-out broadens (agentic AI, custom silicon), 2nm and CoWoS stay sold out, pricing holds, and EPS compounds from $26.50 in 2027 to $64 by 2031 with the market paying 22–24x.
NTM EPS ≈ $31.5 → $68.0 (mid-2027 → mid-2031) × 24x → 22x = $756 → $1,496 · 5-yr price CAGR ≈ +31%/yr
▸ Base case — show the assumptions & math
2027 follows Street (NT$148.61 per share, ≈$23.22 per ADR); we then grow EPS 26%, 20%, 16%, 13% as growth fades toward the teens, and the multiple holds near today’s ≈19.5x before easing to 18x.
NTM EPS ≈ $26.2 → $48.6 × 19.5x → 18x = $512 → $874 · 5-yr price CAGR ≈ +17%/yr
▸ Bear case — show the assumptions & math
AI customers digest a record build, utilization and pricing soften while depreciation from $60B+ a year of capex climbs, 2nm and overseas dilution persist, and the market pays an old-cyclical 13–14x. 2027 EPS lands ≈16% below Street.
NTM EPS ≈ $20.0 → $28.0 × 13x → 14x = $260 → $392 · 5-yr price CAGR ≈ -2%/yr
05 · Follow the cash

Revenue, capex, free cash flow & debt (NT$ trillions)

Where the money goes. The bull and bear theses both live in the gap between the capex and free-cash-flow bars.

Annual revenue, capex, FCF & total debt · 2023 → 2026E
REVENUECAPEXFREE CASH FLOWTOTAL DEBT
NT$0TNT$1.5TNT$3TNT$4.5TNT$6T 2023202420252026E

Reported in NT$ to avoid currency distortion (S&P Global). 2023–25 are actual; lighter 2026E bars are estimates: revenue and FCF per consensus (NT$5.56T and NT$1.45T), capex at the $60–64B budget midpoint × NT$32 ≈ NT$1.98T. Total debt is gross (NT$0.82T at Sep 30, 2026) against NT$4.02T of cash and short-term investments, a net-cash business. Capex jumped from NT$0.96T to NT$1.27T in 2025 and is heading higher; revenue is growing faster, so FCF still compounds. The bear’s case is that the capex bar keeps climbing after revenue stops.

06 · Earnings power

EPS path underpinning the targets ($ per ADR)

Each price target is an EPS estimate times an exit multiple. Here is the earnings ladder the scenarios are built on.

EPS per ADR unit · reported vs. estimated, 2024 → 2031E
REPORTEDESTIMATE
$0$12$24$36$48 202420252026E2027E2028E*2029E*2030E*2031E* $6.98 $10.35 $17.21 $23.22 $29.26 $35.11 $40.73 $46.02

One ADR = 5 ordinary shares; converted at a constant NT$32 per US$ (Q3’26 EPS of NT$29.43 = US$4.60 per ADR implies 31.99), so growth is not a currency artifact. Gray = reported (2024 derived from net income ÷ 25.93B shares); olive = estimates. 2026E–2027E are Street (NT$110.13 and NT$148.61, S&P Global); starred 2028E–2031E are our base case. The base ≈ $47 of 2031 EPS at ≈18x ≈ the $874 five-year base target.

07 · Growth scorecard

The business is still accelerating

Q3 FY26, year-over-year — read these against a stock 12.5% below its high.

Year-over-year growth by metric · Q3 FY26
CORE (REPORTED)FORWARD / INFLECTING
Revenue (US$) +41% Revenue (NT$) +51% Q4 guide, midpoint +58% Gross profit (NT$) +69% Net income / EPS +69% Operating profit (US$) +75% Free cash flow >3x (+200%+)

Every line is above +40%, with profit growing faster than revenue. Olive = reported Q3 lines (TSMC release, Oct 15, 2026; operating-profit and FCF growth per Hargreaves Lansdown’s summary of the results); clay = Q4 guidance midpoint (+58% YoY, CNA) and free cash flow, which more than tripled to ≈$14.9B. FCF bar capped at +200% for display. Net margin is 51.1%. The disconnect between this chart and a falling price is the bull case.

08 · The debate

Bull vs. Bear

The valuation argument compresses into one disagreement: is TSMC the toll road every AI dollar must cross, or a capex-hungry cyclical at peak yield?

▲ THE BULL CASE

  • Record quarter, raised outlook. Revenue $46.72B (+41%), above the top of guidance; 2026 growth now ≈44% versus “slightly above 40%” in July.
  • Q4 guide is a step up. $52.3–54.3B implies +58% YoY at the midpoint and roughly 14% sequential growth.
  • Pricing power survives the ramp. Gross margin 66.4% (inside the 65–67% range) while 2nm went from 3% to 8% of wafer revenue.
  • Demand exceeds supply. CoWoS packaging stays tight; management says demand remains “well above” capacity and sees “no sign of a slowdown.”
  • Fortress balance sheet. ≈$100B net cash, debt/EBITDA 0.23x, ROIC ≈60%, and a dividend that grew 32% last year.
  • The multiple already reset. Forward P/E ≈19.5x versus ≈24.5x in January, in line with the S&P 500 at ≈20.3x and with Nvidia at ≈19.9x, for a company growing EPS 35%+.

▼ THE BEAR CASE

  • Capex is a one-way ratchet. $60–64B in 2026 (from $52–56B in January); 2026–28 guided “significantly higher” than the prior three years. TTM FCF yield is only ≈2.4%.
  • Good news no longer lifts the stock. TSM fell 1.8% on the day of a beat-and-raise and 11.5% in seven sessions as the AI trade unwound on debt and rate worries.
  • Margin dilution is guided. 2nm dilutes gross margin 2–4 points and overseas fabs another 2–4; Q3 margin slipped to 66.4% from 67.7%.
  • Customer concentration. HPC is 68% of revenue; a hyperscaler or neocloud pause (the CoreWeave worry) hits the biggest line directly.
  • Taiwan concentration and policy. Most leading-edge capacity is on one island, and chip-tariff terms with Washington keep shifting.
  • The multiple is not cheap on trailing numbers. 27.8x trailing, 8.6x book and 12.3x sales; a JLPascual Sell at $262 shows where the bear’s math lands.
09 · Risk map

Risk map — likelihood × impact

Where each risk sits, not just how big it is. The hot corner — likely and high-impact — is AI sentiment, which has already moved the stock; the worst-case tail (a Taiwan Strait shock) sits in the Tail row by design.

Low impact
Medium impact
High impact
Likely
  • NT$ swings
  • Margin dilution
  • Capex creep
  • AI de-rating
Possible
  • Rival 2nm share
  • Arizona costs
  • AI capex digestion
  • US chip tariffs
Tail
  • Taiwan Strait shock

AI-sentiment de-rating

Likely × High

It just happened: a CoreWeave-debt post and a Broadcom casino comment cut TSM about 11% in seven sessions, and the forward multiple is already down from ≈24.5x to ≈19.5x. Another leg lower in AI sentiment moves the stock more than earnings do.

AI capex digestion

Possible × High

Hyperscalers and neoclouds pause orders after a record build. With HPC at 68% of revenue and capex at $60–64B, utilization slips while depreciation keeps rising.

US chip tariffs

Possible × High

Washington has threatened steep duties on foreign-made chips; a US–Taiwan deal reportedly lowers rates in exchange for US investment. A reversal re-prices cost and customer demand.

Margin dilution

Likely × Medium

Management guides 2nm to dilute gross margin 2–4 points and overseas fabs 2–4 more; Q3 margin already slipped to 66.4% from 67.7%.

Capex creep

Likely × Medium

The 2026 budget went from $52–56B to $60–64B in six months, and 2026–28 is guided higher still. Free cash flow yield stays thin.

Taiwan Strait shock

Tail × High

A blockade, conflict or severe quake at the Hsinchu and Tainan clusters: low odds, but most leading-edge capacity sits on one island.

Rival 2nm share

Possible × Medium

Samsung and Intel foundry win a marquee 2nm or A16-class design, capping pricing power at the margin.

Arizona costs

Possible × Medium

A $265B US build-out (3nm Fab 2 now complete) brings higher costs and lower yields before it reaches scale.

NT$ swings

Likely × Low

A stronger Taiwan dollar erodes margin on NT$ costs against US$ revenue; EPS in NT$ and US$ can diverge.

10 · Plain-language glossary

The jargon, decoded

Hover the dotted terms in the metrics, or scan the desk’s working definitions here.

ADR unit
The NYSE-listed certificate worth 5 ordinary Taiwan shares. All per-share figures here are per ADR, converted at NT$32 per US$.
2nm / 3nm (N2 / N3)
Chip-making process generations; smaller is faster and more efficient and costs more to build. 2nm was 8% of wafer revenue in Q3, 3nm 33%.
CoWoS
TSMC’s advanced packaging that links AI processors to memory. It is the current bottleneck for AI accelerators.
Gross margin
Revenue less cost of making the wafers, as a share of revenue. Ramping 2nm and overseas fabs dilutes it by a few points.
Capex
Money spent on fabs and tools. $60–64B in 2026; it is what separates operating cash flow from free cash flow.
Free cash flow yield
Free cash flow ÷ market value. About 2.4% here: the cash is large, but the stock price is larger and capex is rising.
Exit multiple
The forward P/E assumed at the end of a forecast. Multiply it by next-twelve-months EPS to get the scenario price.
Prob-weighted
Each scenario’s price × its probability, summed into one expected value across bear, base and bull. Use the sliders to change the weights.
NOT FINANCIAL ADVICE

Sources & method (as of Oct 20, 2026 close): TSMC Q3 2026 earnings release and Form 6-K (Oct 15, 2026); Q1–Q3 2026 earnings-call coverage (VectorShift, VanEck, Focus Taiwan/CNA, Oct 15); price, statistics, financials and consensus from StockAnalysis.com (S&P Global Market Intelligence, last updated Oct 20, 2026); individual targets from TipRanks (Oct 15–19); 52-week low and monthly anchors from Barchart, Dow Jones Market Data/FactSet and TipRanks historical prices; selloff context from SiliconANGLE, Techloy (Reuters data), Computing and Business Recorder (Oct 15–16); peer multiples from Benzinga/TradingView (Oct 2026) and Motley Fool (Jan 14, 2026); free cash flow and net cash at quarter-end from Hargreaves Lansdown. Conflicts and judgment calls: (1) S&P lists market cap $1.91T, apparently off the Taiwan-line price; we use the ADR basis (5.186B ADR units × $425.08 ≈ $2.20T), which matches Bloomberg’s $2.45T at the Oct 7 price. (2) Net cash is $100.4B (S&P, Sep 30) versus $93.6B (HL); we show S&P. (3) S&P’s lowest target is $440 but TipRanks shows a $262 Sell. (4) EPS per ADR uses a constant NT$32 rate; 2024 EPS is derived. (5) Dec 31, 2025 close ≈ $304 is derived from Dow Jones’s +33% YTD figure; Nov 21, 2025 low and Mar 2026 points are intraday extremes from Barchart; Jul 30, 2026 is derived from Dow Jones’s intraday move. Scenario prices are illustrative midpoints, not forecasts; actual outcomes can fall outside the cone. The six analyst lenses are synthesized frameworks, not real people or real firm ratings. Not financial advice — do your own research and consider consulting a licensed financial advisor.